This post is the first a series in which we are inviting industry experts & veterans to discuss topics critical to successful biopharma development programs, with a particular focus on issues often encountered by life sciences entrepreneurs. In today's edition, Paul Ginsburg discusses patent strategy for early stage biopharma companies and provides important checklists that...